We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

SiMa.ai, the software-centric, embedded edge machine learning system-on-chip (MLSoC) company, has been named to Fast Company's prestigious list of the world's Most Innovative Companies for 2025.

According to the latest study from BCC Research, "Softgel Capsules: Global Markets" is expected to grow from $7.9 billion in 2024 to ...

The stock's rise snapped a four-day losing streak.

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...

Shares of Thermo Fisher Scientific Inc. TMO slid 2.39% to $514.20 Tuesday, on what proved to be an all-around rough trading ...

Explore Thermo Fisher's latest developments in transmission electron microscopy (TEM) technology, specifically focusing on ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$429.2 million ...

The global PFAS Testing Market, valued at US$379.2 million in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching ...

Citi lowered the firm’s price target on Thermo Fisher (TMO) to $570 from $650 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the ...